MyRxProfile is a medication management and interaction-tracking app for families on iOS.
Product velocity
Maintenance
Daily rank 🇺🇸
—
Medical
Sentiment
3.4
34 reviews
Nemesis
Fragmented field
The App DNA
What makes this app unique?
It removes the cognitive load of tracking complex medication schedules across multiple family members, though its current reliability issues limit its utility as a safety tool.
For Individuals and families managing complex, multi-medication regimens who require centralized safety monitoring.
What does it look like?
Key features
Identifies potential clashes between medications and supplements.
Supports multiple personalized medication spaces within a single account.
Uses device camera to scan barcodes for medication identification.
How much does it cost?
The subscription-only model gates all core functionality, including safety alerts, creating a high conversion risk when the interaction engine fails to perform.
Velocity
Maintenance developmentperformanceopaqueShow more...
The app maintains a maintenance-level cadence, shipping approximately 0.12 releases per week. Development is currently focused exclusively on stability and bug fixes, with no new features or live-ops content introduced in recent updates. The latest release continues this pattern of opaque, minor maintenance. The development trend remains stable at this low-frequency pace.
Who built it?
User Sentiment
What do users think recently?
The recent review mood reads frustrated. Users appreciate detailed drug information and interaction warnings provide value for users managing multiple complex medication regimens and the user interface is described as visually appealing and easy to navigate for new users.
How are ratings & reviews evolving?
What users say, by theme
- Detailed drug information and interaction warnings provide value for users managing multiple complex medication regimens
- The user interface is described as visually appealing and easy to navigate for new users
- Critical drug interaction checks fail to flag dangerous combinations, creating significant safety risks for users
14 of 14 recent reviews analyzed · moderate confidence · Frustrated overall
Read the full review analysisUnlock 2 more frustration themes and 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for MyRxProfile: Pill & Drug Guide
How's the Medical market?
MyRxProfile holds a 3.35-star rating across 34 total ratings. The subscription-only model, combined with a maintenance-only update cadence, leaves the app vulnerable to competitors that offer free, reliable interaction checks.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for MyRxProfile: Pill & Drug Guide
Where is it heading?
The medication management market is consolidating around tools that prioritize high-accuracy safety alerts. MyRxProfile's current maintenance-only cadence and reported interaction failures leave it exposed to churn, as users prioritize reliability over the app's family-profile features.
- Critical failures in the interaction engine destroy user trust, which compounds the churn risk already present in the subscription-only model.
- Maintenance-only update cadence leaves the app exposed to competitors that can ship stable, feature-rich updates more frequently.
The SWOT
- Family-specific medication spaces allow for centralized safety monitoring across households
- Manual entry feature for missing medications would address the top user frustration regarding the limited database
Next best moves
Ship manual medication entry because it is the top-requested feature → reduce churn from database limitations
+ 1 more prioritized moveThe counter-intuitive read
The subscription-only model is a liability, not an asset: in a safety-critical category…
Read the full takeSince the last report: The app remains in a maintenance-only state with no functional changes or feature releases. The primary shift is a more critical framing of the subscription-only model as a liability against free, reliable market alternatives.
Bottom line
The core interaction engine must be audited to restore safety-tool credibility, as current failures in flagging dangerous combinations are driving negative sentiment and churn. Addressing this reliability gap is the only way to justify the subscription-only model.
Unlock 2 critical frictions, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated